Explore All Access
Check if your research matches the topics covered in Journal of Modern Oncology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Journal of Modern Oncology : Impact Factor & More
eISSN: 1815-1442pISSN: 1815-1434
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Journal of Modern Oncology Key Metrics
CiteScore 
0.2
H-Index
3
SJR
Q4Oncology
SNIP
0.05
Topics Covered on Journal of Modern Oncology
Clinical case
Cancer
Breast cancer
Differential diagnosis
Neutropenia
Myelosuppressive therapy
Myocardial infarction
Left external iliac artery
Metastatic breast cancer
Sorafenib
Febrile neutropenia
Triple-negative breast cancer
Surgical treatment
Quality of life
Imatinib
Chronic pain
Brain magnetic resonance imaging
Eribulin
Hepatocellular carcinoma
Lenvatinib
Journal of Modern Oncology Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Consilium Medikum |
| Language | Russian |
| Article Processing Charges | EUR 630 |
| Publication Time | 5 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | Russian |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Journal of Modern Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Journal of Modern Oncology
What are the harms and benefits of using pegylated liposomal doxorubicin in women with recurrent epithelial ovarian cancer, alone or in combination with other drugs? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
- 11 Nov 2024
- Journal of Modern Oncology
Comparative analysis of efficacy and safety of combined immunotherapy and immune targeted therapy in the first-line treatment of advanced renal cell carcinoma: a real-world study
- 11 Nov 2024
- Journal of Modern Oncology
The combination of lenvatinib and pembrolizumab in the treatment of patients with metastatic kidney cancer and factors of poor prognosis: experience of clinics in Moscow: A prospective observational study
- 11 Nov 2024
- Journal of Modern Oncology
Increasing the effectiveness of total-skin electron beam therapy by reducing the manifestations of radiation dermatitis in patients with primary lymphomas. A comparative randomized prospective study
- 11 Nov 2024
- Journal of Modern Oncology
Role of immunohistochemical prognostic factors in various types of immunotherapy for metastatic melanoma: A retro-prospective study
- 11 Nov 2024
- Journal of Modern Oncology
Current state of care for cancer patients with HIV in Russia: Data from an oncologist survey
- 11 Nov 2024
- Journal of Modern Oncology
What are the harms and benefits of using pegylated liposomal doxorubicin in women with recurrent epithelial ovarian cancer, alone or in combination with other drugs? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
- 11 Nov 2024
- Journal of Modern Oncology
Comparative analysis of efficacy and safety of combined immunotherapy and immune targeted therapy in the first-line treatment of advanced renal cell carcinoma: a real-world study
- 11 Nov 2024
- Journal of Modern Oncology
The combination of lenvatinib and pembrolizumab in the treatment of patients with metastatic kidney cancer and factors of poor prognosis: experience of clinics in Moscow: A prospective observational study
- 11 Nov 2024
- Journal of Modern Oncology
Increasing the effectiveness of total-skin electron beam therapy by reducing the manifestations of radiation dermatitis in patients with primary lymphomas. A comparative randomized prospective study
- 11 Nov 2024
- Journal of Modern Oncology
Role of immunohistochemical prognostic factors in various types of immunotherapy for metastatic melanoma: A retro-prospective study
- 11 Nov 2024
- Journal of Modern Oncology
Current state of care for cancer patients with HIV in Russia: Data from an oncologist survey
- 11 Nov 2024
- Journal of Modern Oncology
Compare Similar Journals with Journal of Modern Oncology
Select Journals to Compare with Journal of Modern Oncology
Total journals - 10
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Medicine
Publisher: Elsevier
Annals of Oncology
Publisher: ELSEVIER
Cancers
Publisher: MDPI
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
BMC Cancer
Publisher: BMC
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Oncotarget
Publisher: Impact Journals
ANNALS OF TRANSLATIONAL MEDICINE
Publisher: AME PUBL CO
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
0 Journals Selected to compare with
Journal of Modern Oncology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Journal of Modern Oncology
How many articles did Journal of Modern Oncology publish last year? 
In 2023, Journal of Modern Oncology publsihed 79 articles.
What is the eISSN & pISSN for Journal of Modern Oncology?
For Journal of Modern Oncology, eISSN is 1815-1442 and pISSN is 1815-1434.
What is Citescore for Journal of Modern Oncology?
Citescore for Journal of Modern Oncology is 0.2.
What is the H Index for Journal of Modern Oncology ?
H Index for Journal of Modern Oncology is 3.
What is SNIP score for Journal of Modern Oncology?
SNIP score for Journal of Modern Oncology is 0.05.
What is the SJR for Journal of Modern Oncology?
SJR for Journal of Modern Oncology is Q4.
Who is the publisher of Journal of Modern Oncology?
Consilium Medikum is the publisher of Journal of Modern Oncology.
